Atlantic Union Bankshares Corp Increases Position in Colgate-Palmolive (NYSE:CL)

Atlantic Union Bankshares Corp lifted its stake in Colgate-Palmolive (NYSE:CL) by 8.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,555 shares of the company’s stock after purchasing an additional 435 shares during the period. Atlantic Union Bankshares Corp’s holdings in Colgate-Palmolive were worth $500,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CL. Register Financial Advisors LLC acquired a new position in shares of Colgate-Palmolive during the 1st quarter worth approximately $48,000. Capital Asset Advisory Services LLC lifted its position in Colgate-Palmolive by 17.7% during the first quarter. Capital Asset Advisory Services LLC now owns 24,149 shares of the company’s stock valued at $2,122,000 after buying an additional 3,636 shares in the last quarter. Fifth Third Wealth Advisors LLC purchased a new stake in Colgate-Palmolive during the first quarter worth approximately $245,000. Hengehold Capital Management LLC increased its position in shares of Colgate-Palmolive by 12.4% in the first quarter. Hengehold Capital Management LLC now owns 3,630 shares of the company’s stock worth $327,000 after acquiring an additional 400 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its stake in shares of Colgate-Palmolive by 5.6% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 205,949 shares of the company’s stock valued at $18,546,000 after acquiring an additional 10,844 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the sale, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares in the company, valued at approximately $297,328.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the transaction, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on CL. Royal Bank of Canada increased their price target on Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a report on Monday, April 29th. Citigroup increased their target price on Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, April 16th. Evercore ISI upped their price target on Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a report on Monday, April 8th. Wells Fargo & Company lifted their price objective on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a research note on Monday, April 29th. Finally, Stifel Nicolaus upped their target price on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, April 29th. Three research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $93.83.

Colgate-Palmolive Stock Performance

NYSE CL traded down $1.18 during trading hours on Friday, hitting $96.99. The company had a trading volume of 11,035,083 shares, compared to its average volume of 4,506,708. The firm has a market cap of $79.57 billion, a P/E ratio of 30.69, a price-to-earnings-growth ratio of 3.62 and a beta of 0.39. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $99.08. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. The business has a fifty day simple moving average of $93.87 and a 200-day simple moving average of $87.51.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. The company had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.73 EPS. Equities analysts predict that Colgate-Palmolive will post 3.53 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a $0.50 dividend. The ex-dividend date is Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.06%. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.